Savarirayan R et alachondroplasiainfigratinibnavepegritidevosoritideNEJMoa2604565NEJM 2026
…nesis is called infigratinib and this is given in an oral form. Savarirayan R et al [NEJM 2026 DOI: 10.1056/NEJMoa2604565] have published the resul…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: Savarirayan R et al ×
Savarirayan R et al
This institution is selected. Its supporting articles are shown below.